MedPath

Evaluation of Carbohydrates

Not Applicable
Completed
Conditions
Glycemic Index
Registration Number
NCT03242122
Lead Sponsor
Abbott Nutrition
Brief Summary

The study is open-label with a randomized, cross-over design using standard Gl methodology.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Subjects are males or non-pregnant females in good health.
  • Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion Criteria
  • Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes or a heart condition.
  • Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Blood glucose response curve0 to 120 minutes

area under the curve (AUG)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Glycemic Index Laboratories Inc

🇨🇦

Toronto, Ontario, Canada

Glycemic Index Laboratories Inc
🇨🇦Toronto, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.